ARTICLE | Clinical News
AeroDose albuterol: Began Phase II testing
January 16, 2001 8:00 AM UTC
AeroGen Inc. (AEGN), Sunnyvale, Calif. Product: AeroDose albuterol Business: Drug delivery Therapeutic category: Receptor antagonist Target: Beta adrenergic receptors Description: Inhaled albuterol u...